Cell-based model systems are powerful tools for studying signaling pathways, deciphering disease mechanisms, and predicting drug activities. To highlight some of the exciting areas where the use of cell models is pushing the boundaries in science, technology, and therapy, ATCC is partnering with The Scientist to present a series of webinars.

The 3-part series will bring together expert researchers to talk about current innovations, applications, and challenges in using cell-based model systems, while highlighting future trends. In each webinar, the panelists will give a brief presentation and then be available to address questions posed by the attendees in real time.

ATCC has been an integral part of biological research for more than 88 years, and is proud to partner with The Scientist in presenting this webinar series on innovative cell research.

Focus on Stem Cell Research

Stem cells provide a unique method for in vitro modeling and screening in a...


Stephen Chang, Ph.D., Vice President of Research and Development, New York Stem Cell Foundation

Hirdesh Uppal, Ph.D., Scientist, Safety Assessment & Development Sciences, Genentech Inc.

Joseph C. Wu, M.D., Ph.D., Director, Stanford Cardiovascular Institute, Professor, Department of Medicine/Cardiology & Radiology, Stanford University School of Medicine

Host-Pathogen Interactions

Heightened resistance to antibiotic drugs and the reduced potency of available vaccines clearly indicate that understanding the dynamics of host-pathogen interactions and the resulting modulation in cell signaling is increasingly imperative. A clearer picture of the underlying molecular mechanisms will result in the development of novel vaccines and therapeutic interventions that will enhance host immunity, circumvent pathogen evasion strategies, and prevent the likelihood of serious infections. Our panel of experts will provide some insight into the progress being made in the exciting study of host-pathogen interactions, and will discuss some of the strategies and technologies they have used when working various viruses, bacteria, and other pathogens.


Abraham Brass, MD, PhD, Assistant Professor, Department of Microbiology and Physiological Systems, University of Massachusetts Medical School

Nihal Altan-Bonnet, PhD, Assistant Professor, Laboratory of Host-Pathogen Dynamics, Department of Biological Sciences, Rutgers University

Scott Grieshaber PhD, Assistant Professor, Department of Oral Biology, School of Dentistry, University of Florida

Focus on Cancer Research

In order to understand the complex mechanisms of tumorigenesis, detecting, interpreting, and exploiting different types of information from human cancer cells, is now a central focus for both basic researchers and drug development scientists. Our panel of experts will provide some insight into the progress being made, while highlighting the factors that have made it possible. They will discuss the imperative need to start out with the highest-quality cells and biological samples for research, to establish rigorous standards for sample and data collection and storage, and to develop a collaboration platform for the effective analysis and sharing of data obtained from disparate sources.


Jaspal Khillan, PhD, Research Associate Professor, Department of Microbiology & Molecular Genetics, University of Pittsburgh

Sophie Lelievre, DVM, LLM, PhD, Associate Professor, Department of Basic Medical Sciences and Associate Director, Discovery Groups, NCI-designated Purdue Center for Cancer Research, Purdue University

Lesley Mathews, PhD, Research Scientist, Biomolecular Screening and Profiling/Probe Development, National Institutes of Health (NIH)

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?